Suppr超能文献

地胆草醇治疗对 NLRP3 炎性小体和焦亡的潜在影响及其在 D-半乳糖和氯化铝诱导的小鼠脑内阿尔茨海默病样病变中的作用。

The potential effects of festidinol treatment against the NLRP3 inflammasome and pyroptosis in D-galactose and aluminum chloride-induced Alzheimer's-like pathology in mouse brain.

机构信息

Department of Anatomy, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

出版信息

Int Immunopharmacol. 2023 Jun;119:110181. doi: 10.1016/j.intimp.2023.110181. Epub 2023 Apr 27.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that causes cognitive and memory decline. Neuroinflammation is currently considered as being an important pathology in AD. NLRP3, the nucleotide-binding and oligomerization (NOD) domain-like receptor (NLR) family pyrin domain (PYD)-containing 3 (NLRP3) inflammasome is a critical component of the innate immune response, which plays a key role in the development and progression of AD. Therefore, the NLRP3 inflammasome is one of the target treatments for AD. This study aimed to investigate the effect of festidinol, a flavanol isolated from Dracaena conferta, against NLRP3 inflammasome and blood-brain barrier damage in D-galactose and aluminum chloride-induced mice. The induced mice received D-galactose (150 mg/kg) and aluminum chloride (10 mg/kg) intraperitoneally for 90 days to generate cognitive impairment. Festidinol (30 mg/kg) and donepezil (5 mg/kg) were given by oral gavage for 90 days along with the induction. Then, learning and memory behavior, and molecular and morphological changes in the brain, which related to NLRP3 inflammasome, pyroptosis and the blood-brain barrier were measured. The results indicated that festidinol markedly decreased the escape latency and increased the time in the target quadrant in the Morris water maze test. Furthermore, festidinol significantly decreased the ionized calcium-binding adapter molecule 1 (Iba-1) and glial fibrillary acidic protein (GFAP) expression. Festidinol also markedly decreased the NLRP3 inflammasome pathway, interleukin 1 beta (IL-1β), gasdermin-D, N-terminal (GSDMD-N) and caspase-3. Pertinent to the blood-brain barrier, festidinol only decreased tumor necrosis factor-α and matrix metallopeptidase-9, but did not restore the tight junction components. In conclusion, festidinol can restore learning and memory and provide a protective effect against the NLRP3 inflammasome and pyroptosis.

摘要

阿尔茨海默病(AD)是一种进行性神经退行性疾病,可导致认知和记忆能力下降。神经炎症目前被认为是 AD 的重要病理学机制。NLRP3 炎性小体是先天免疫反应的关键组成部分,NLRP3 炎性小体,核苷酸结合寡聚化结构域样受体(NLR)家族富含pyrin 结构域(PYD)3(NLRP3)炎性小体,在 AD 的发展和进展中起关键作用。因此,NLRP3 炎性小体是 AD 的治疗靶点之一。本研究旨在探讨从龙血树中分离得到的黄烷醇 festidinol 对 D-半乳糖和氯化铝诱导的小鼠 NLRP3 炎性小体和血脑屏障损伤的作用。诱导小鼠腹腔内注射 D-半乳糖(150mg/kg)和氯化铝(10mg/kg)90 天,以产生认知障碍。Festidinol(30mg/kg)和多奈哌齐(5mg/kg)经口灌胃 90 天,同时进行诱导。然后,测量与 NLRP3 炎性小体、细胞焦亡和血脑屏障相关的学习和记忆行为以及大脑的分子和形态变化。结果表明, festidinol 显著降低了 Morris 水迷宫测试中的逃避潜伏期,并增加了目标象限中的时间。此外, festidinol 显著降低了离子钙结合衔接分子 1(Iba-1)和胶质纤维酸性蛋白(GFAP)的表达。Festidinol 还显著降低了 NLRP3 炎性小体途径、白细胞介素 1β(IL-1β)、gasdermin-D、N 端(GSDMD-N)和半胱天冬酶-3。与血脑屏障相关的是, festidinol 仅降低了肿瘤坏死因子-α和基质金属蛋白酶-9,但未恢复紧密连接成分。总之, festidinol 可以恢复学习和记忆,并提供针对 NLRP3 炎性小体和细胞焦亡的保护作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验